rs1267037

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The ENST00000421122.8(PSMD14-DT):​n.385+6880T>G variant causes a intron change. The variant allele was found at a frequency of 0.701 in 152,078 control chromosomes in the GnomAD database, including 39,019 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.70 ( 39019 hom., cov: 32)

Consequence

PSMD14-DT
ENST00000421122.8 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 5.44

Publications

7 publications found
Variant links:
Genes affected
PSMD14-DT (HGNC:56104): (PSMD14 divergent transcript)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000421122.8, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.797 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000421122.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PSMD14-DT
NR_110593.1
n.348+6880T>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PSMD14-DT
ENST00000421122.8
TSL:3
n.385+6880T>G
intron
N/A
PSMD14-DT
ENST00000445372.5
TSL:3
n.229+6880T>G
intron
N/A
PSMD14-DT
ENST00000803724.1
n.271+6880T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.702
AC:
106628
AN:
151960
Hom.:
39021
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.471
Gnomad AMI
AF:
0.798
Gnomad AMR
AF:
0.795
Gnomad ASJ
AF:
0.702
Gnomad EAS
AF:
0.818
Gnomad SAS
AF:
0.751
Gnomad FIN
AF:
0.724
Gnomad MID
AF:
0.763
Gnomad NFE
AF:
0.803
Gnomad OTH
AF:
0.712
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.701
AC:
106655
AN:
152078
Hom.:
39019
Cov.:
32
AF XY:
0.703
AC XY:
52252
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.471
AC:
19509
AN:
41434
American (AMR)
AF:
0.795
AC:
12161
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.702
AC:
2438
AN:
3472
East Asian (EAS)
AF:
0.818
AC:
4240
AN:
5184
South Asian (SAS)
AF:
0.751
AC:
3619
AN:
4822
European-Finnish (FIN)
AF:
0.724
AC:
7656
AN:
10576
Middle Eastern (MID)
AF:
0.765
AC:
225
AN:
294
European-Non Finnish (NFE)
AF:
0.803
AC:
54587
AN:
67984
Other (OTH)
AF:
0.708
AC:
1494
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1484
2968
4452
5936
7420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.678
Hom.:
5509
Bravo
AF:
0.700
Asia WGS
AF:
0.728
AC:
2532
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
22
DANN
Benign
0.81
PhyloP100
5.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1267037;
hg19: chr2-162098155;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.